Susan P. Whitman
Dr. Susan Whitman was awarded a B.S. in Biological Sciences from Marshall University (1987), a M.S. in Chemistry from the University of North Carolina at Greensboro (1991) and a Ph.D. in Biochemistry from Wake Forest Baptist Medical Center's Department of Biochemistry (1996). She joined the laboratory of world-renowned physician scientist, Dr. Michael A. Caligiuri, M.D. at The Ohio State University as a postdoctoral fellow in 1997 and then moved to her current position as a Research Scientist with Principal Investigator status in the OSU Department of Internal Medicine, Division of Hematology-Oncology in 2001. She has since joined the OSU NCI-designated Comprehensive Cancer Center and works closely with her mentor, Dr. Clara D. Bloomfield, M.D., the first person to suggest and demonstrate that older patients with acute leukemia can be cured with chemotherapy. Dr. Whitman's current research bridges both the basic sciences (molecular genetics of AML) and translational medicine (murine models of human acute myeloid leukemia; preclinical drug studies; and clinical correlative studies for predictive and prognostic biomarkers in AML). In 2001, Dr. Whitman was recognized as one of the top ten Young Cancer Scholars in the U.S.A. by the General Motor Corporation's Cancer Research Foundation. She has also been awarded with funding from the NCI, NIGMS and the NDDK of the U.S.A.'s NIH. Dr. Whitman has over 45 publications in peer-reviewed journals, including Blood, the Journal of Clinical Oncology, the Journal of Clinical Investigation and the New England Journal of Medicine.
Biography Updated on 24 September 2012